APOE polymorphisms affect the risk of progressive supranuclear palsy, which does not feature Aβ pathology (Zhao et al., 2018), and APOE alleles modulate tau pathology independent of Aβ in animal models (Shi et al., 2019). The gene discussed is MAPT; the disease is Classical progressive supranuclear palsy.